New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Vascular Biogenics Ltd.
VBLT
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

12M

Biotechnology

0.16USD

Shape-0.01 ( -8.77%)
Market Closed (as of Oct 16, 20:00 EDT)
favorite-chart

Relative Strenght

31
favorite-chart

Volume Buzz

583%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

51%

Quote Panel

Shape
Updated March 22, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

VBLT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Morgan Stanley

upgrade

Previous: Not converted

2022-07-20

Now: Overweight

Chardan Capital

initialise

Previous: Not converted

2022-04-28

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.21

arrow
arrow

N/A

-0.12
vs -0.15

Q2.21

arrow
arrow

N/A

-0.12
vs -0.14

Q3.21

arrow
arrow

N/A

-0.09
vs -0.12

Q4.21

arrow
arrow

N/A

-0.12
vs -0.15

Q1.22

arrow
arrow

N/A

-0.13
vs -0.12

Q2.22

arrow
arrow

N/A

-0.12
vs -0.12

Q3.22

arrow
arrow

N/A

-0.12
vs -0.09

Q4.22

arrow
arrow

N/A

-0.05
vs -0.12

Q1.23

arrow
arrow

N/A

-0.03
vs -0.13

Q2.23

arrow
arrow

N/A

-0.01
vs -0.12

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.21

arrow
arrow

-49%

185K  vs 366K

Q2.21

arrow
arrow

+19%

188K  vs 158K

Q3.21

arrow
arrow

+3%

199K  vs 193K

Q4.21

arrow
arrow

-4%

196K  vs 205K

Q1.22

arrow
arrow

-39%

113K  vs 185K

Q2.22

arrow
arrow

-66%

64K  vs 188K

Q3.22

arrow
arrow

+142%

481K  vs 199K

Q4.22

arrow
arrow

-42%

113K  vs 196K

Q1.23

arrow
arrow

-100%

NA  vs 113K

Q2.23

arrow
arrow

-100%

NA  vs 64K

Return on EquityShape

status-upQoQ

Q1.22

arrow
arrow

-24%

-0.24
vs -0.17

Q2.22

arrow
arrow

-27%

-0.27
vs -0.24

Q3.22

arrow
arrow

-36%

-0.36
vs -0.27

Q4.22

arrow
arrow

-15%

-0.15
vs -0.36

Q1.23

arrow
arrow

-13%

-0.13
vs -0.15

Q2.23

arrow
arrow

-5%

-0.05
vs -0.13

Q1.24

arrow
arrow

-33%

-0.33
vs -0.05

Q2.24

arrow
arrow

-73%

-0.73
vs -0.33

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

30

30
vs 32

-6%

Q1.22

arrow
arrow

30

30
vs 30

NA

Q2.22

arrow
arrow

34

34
vs 30

13%

Q3.22

arrow
arrow

25

25
vs 34

-26%

Q4.22

arrow
arrow

25

25
vs 25

NA

Q1.23

arrow
arrow

15

15
vs 25

-40%

Q2.23

arrow
arrow

16

16
vs 15

7%

Q3.23

arrow
arrow

22

22
vs 16

38%

Earnings Growth

Latest News